Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Cervical Cancer

  Free Subscription


Articles published in Radiother Oncol

Retrieve available abstracts of 51 articles:
HTML format



Single Articles


    September 2021
  1. PETERS M, de Leeuw AAC, Nomden CN, Tanderup K, et al
    Risk factors for nodal failure after radiochemotherapy and image-guided brachytherapy in locally advanced cervical cancer: an EMBRACE analysis.
    Radiother Oncol. 2021 Sep 1. pii: S0167-8140(21)06714.
    PubMed     Abstract available


    May 2021
  2. MAHANTSHETTY U, Poetter R, Beriwal S, Grover S, et al
    IBS-GEC ESTRO-ABS Recommendations for CT Based Contouring in Image Guided Adaptive Brachytherapy for Cervical cancer.
    Radiother Oncol. 2021 May 17. pii: S0167-8140(21)06248.
    PubMed     Abstract available


  3. YUCE SARI S, Yigit E, Gultekin M, Yildiz F, et al
    In regard to Spampinato et al.
    Radiother Oncol. 2021;158:321-322.
    PubMed    


  4. SPAMPINATO S, Fokdal LU, Potter R, Haie-Meder C, et al
    Response to Yuce Sari et al.
    Radiother Oncol. 2021;158:323-324.
    PubMed    


    April 2021
  5. MOHAMMADI R, Shokatian I, Salehi M, Arabi H, et al
    Deep learning-based Auto-segmentation of Organs at Risk in High-Dose Rate Brachytherapy of Cervical Cancer.
    Radiother Oncol. 2021 Apr 5. pii: S0167-8140(21)06170.
    PubMed     Abstract available


    March 2021
  6. HUMPHREY P, Dures E, Hoskin P, Cramp F, et al
    Brachytherapy for locally advanced cervical cancer: a survey of UK provision of care and support.
    Radiother Oncol. 2021 Mar 16. pii: S0167-8140(21)06133.
    PubMed     Abstract available


    February 2021
  7. SPAMPINATO S, Fokdal LU, Potter R, Haie-Meder C, et al
    Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: an EMBRACE analysis.
    Radiother Oncol. 2021 Feb 2. pii: S0167-8140(21)00020.
    PubMed     Abstract available


    January 2021
  8. PETRIC P, Lindegaard JC, Sturdza A, Fokdal L, et al
    Results of Image guided brachytherapy for stage IB cervical cancer in the RetroEMBRACE study.
    Radiother Oncol. 2021 Jan 18. pii: S0167-8140(21)00005.
    PubMed     Abstract available


    October 2020
  9. CHOPRA S, Mangaj A, Sharma A, Tee Tan L, et al
    Management of oligo-metastatic and oligo-recurrent cervical cancer: A pattern of care survey within the EMBRACE research network.
    Radiother Oncol. 2020 Oct 31. pii: S0167-8140(20)30884.
    PubMed     Abstract available


  10. SPAMPINATO S, Fokdal LU, Potter R, Haie-Meder C, et al
    Importance of the ICRU Bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: an EMBRACE analysis.
    Radiother Oncol. 2020 Oct 13. pii: S0167-8140(20)30839.
    PubMed     Abstract available


  11. RODRIGUEZ-LOPEZ JL, Ling DC, Keller A, Kim H, et al
    Ureteral Stenosis after 3D MRI-based Brachytherapy for Cervical Cancer - Have We Identified All the Risk Factors?
    Radiother Oncol. 2020 Oct 13. pii: S0167-8140(20)30846.
    PubMed     Abstract available


  12. LIU Z, Liu X, Guan H, Zhen H, et al
    Development and Validation of a Deep Learning Algorithm for Auto-delineation of Clinical Target Volume and Organs at Risk in Cervical Cancer Radiotherapy.
    Radiother Oncol. 2020 Oct 8. pii: S0167-8140(20)30835.
    PubMed     Abstract available


  13. WATANABE Y, Nakamura S, Ichikawa Y, Ii N, et al
    Early Alteration in Apparent Diffusion Coefficient and Tumor Volume in Cervical Cancer Treated with Chemoradiotherapy or Radiotherapy: Incremental Prognostic Value over Pretreatment Assessments.
    Radiother Oncol. 2020 Oct 8. pii: S0167-8140(20)30834.
    PubMed     Abstract available


    September 2020
  14. GORT EM, Beukema JC, Matysiak W, Sijtsema NM, et al
    Inter-fraction motion robustness and organ sparing potential of proton therapy for cervical cancer.
    Radiother Oncol. 2020 Sep 18. pii: S0167-8140(20)30797.
    PubMed     Abstract available


  15. VAN HOUDT PJ, Kallehauge JF, Tanderup K, Nout R, et al
    Phantom-based quality assurance for multicenter quantitative MRI in locally advanced cervical cancer.
    Radiother Oncol. 2020 Sep 12. pii: S0167-8140(20)30785.
    PubMed     Abstract available


    June 2020
  16. DUKE SL, Tan LT, Jensen NBK, Rumpold T, et al
    Implementing an online radiotherapy quality assurance programme with supporting continuous medical education - report from the EMBRACE-II evaluation of cervix cancer IMRT contouring.
    Radiother Oncol. 2020;147:22-29.
    PubMed     Abstract available


    May 2020
  17. MENDEZ LC, Raziee H, Davidson M, Velker V, et al
    Should we embrace hypofractionated radiotherapy for cervical cancer? A technical note on management during the COVID-19 pandemic.
    Radiother Oncol. 2020 May 28. pii: S0167-8140(20)30288.
    PubMed     Abstract available


    April 2020
  18. OUD M, Kolkman-Deurloo IK, Mens JW, Lathouwers D, et al
    Fast and fully-automated multi-criterial treatment planning for adaptive HDR brachytherapy for locally advanced cervical cancer.
    Radiother Oncol. 2020;148:143-150.
    PubMed     Abstract available


  19. LI Z, Tamari K, Seo Y, Minami K, et al
    Dihydroouabain, a novel radiosensitizer for cervical cancer identified by automated high-throughput screening.
    Radiother Oncol. 2020;148:21-29.
    PubMed     Abstract available


  20. REIJTENBAGH DMW, Godart J, Mens JM, Heijkoop ST, et al
    Patient-reported acute GI symptoms in locally advanced cervical cancer patients correlate with rectal dose.
    Radiother Oncol. 2020;148:38-43.
    PubMed     Abstract available


  21. SPAMPINATO S, Tanderup K, Marinovskij E, Axelsen S, et al
    MRI-based contouring of functional sub-structures of the lower urinary tract in gynaecological radiotherapy.
    Radiother Oncol. 2020;145:117-124.
    PubMed     Abstract available


  22. SCHMID MP, Fokdal L, Westerveld H, Chargari C, et al
    Recommendations from gynaecological (GYN) GEC-ESTRO working group - ACROP: Target concept for image guided adaptive brachytherapy in primary vaginal cancer.
    Radiother Oncol. 2020;145:36-44.
    PubMed     Abstract available


    February 2020
  23. SWAMIDAS J, Kirisits C, De Brabandere M, Hellebust TP, et al
    Image registration, contour propagation and dose accumulation of external beam and brachytherapy in gynecological radiotherapy.
    Radiother Oncol. 2020;143:1-11.
    PubMed     Abstract available


  24. TRAVERSO A, Kazmierski M, Welch ML, Weiss J, et al
    Sensitivity of radiomic features to inter-observer variability and image pre-processing in Apparent Diffusion Coefficient (ADC) maps of cervix cancer patients.
    Radiother Oncol. 2020;143:88-94.
    PubMed     Abstract available


    September 2019
  25. MAHANTSHETTY U, Sturdza A, Naga Ch P, Berger D, et al
    Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: Clinical feasibility and outcome.
    Radiother Oncol. 2019 Sep 5. pii: S0167-8140(19)33043.
    PubMed     Abstract available


    June 2019
  26. WU Q, Wang S, Chen X, Wang Y, et al
    Radiomics analysis of magnetic resonance imaging improves diagnostic performance of lymph node metastasis in patients with cervical cancer.
    Radiother Oncol. 2019;138:141-148.
    PubMed     Abstract available


    May 2019
  27. NOMDEN CN, Potter R, de Leeuw AAC, Tanderup K, et al
    Nodal failure after chemo-radiation and MRI guided brachytherapy in cervical cancer: Patterns of failure in the EMBRACE study cohort.
    Radiother Oncol. 2019;134:185-190.
    PubMed     Abstract available


    March 2019
  28. FISET S, Welch ML, Weiss J, Pintilie M, et al
    Repeatability and reproducibility of MRI-based radiomic features in cervical cancer.
    Radiother Oncol. 2019;135:107-114.
    PubMed     Abstract available


  29. HO JC, Fang P, Cardenas CE, Mohamed ASR, et al
    Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer.
    Radiother Oncol. 2019;135:58-64.
    PubMed     Abstract available


    November 2018
  30. KEENAN LG, McArdle O
    Delineation guideline for the para-aortic lymph node region in cervical cancer - Clarification letter.
    Radiother Oncol. 2018 Nov 7. pii: S0167-8140(18)33383.
    PubMed    


    June 2018
  31. JENSEN NBK, Potter R, Kirchheiner K, Fokdal L, et al
    Bowel morbidity following radiochemotherapy and image-guided adaptive brachytherapy for cervical cancer: Physician- and patient reported outcome from the EMBRACE study.
    Radiother Oncol. 2018 Jun 4. pii: S0167-8140(18)30275.
    PubMed     Abstract available


    May 2018
  32. LEE J, Wu MH, Chen YJ
    Delineation guideline for the para-aortic lymph node region in cervical cancer.
    Radiother Oncol. 2018 May 26. pii: S0167-8140(18)30251.
    PubMed    


  33. FOKDAL L, Potter R, Kirchheiner K, Lindegaard JC, et al
    Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancer.
    Radiother Oncol. 2018 May 18. pii: S0167-8140(18)30242.
    PubMed     Abstract available


    April 2018
  34. CIBULA D, Potter R, Planchamp F, Avall-Lundqvist E, et al
    The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer.
    Radiother Oncol. 2018 Apr 12. pii: S0167-8140(18)30135.
    PubMed     Abstract available


  35. NAJJARI JAMAL D, Potter R, Haie-Meder C, Lindegaard JC, et al
    Physician assessed and patient reported lower limb edema after definitive radio(chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: A report from the EMBRACE study.
    Radiother Oncol. 2018 Apr 6. pii: S0167-8140(18)30170.
    PubMed     Abstract available


  36. SMET S, Potter R, Haie-Meder C, Lindegaard JC, et al
    Fatigue, insomnia and hot flashes after definitive radiochemotherapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: An analysis from the EMBRACE study.
    Radiother Oncol. 2018 Apr 4. pii: S0167-8140(18)30141.
    PubMed     Abstract available


    March 2018
  37. KEENAN LG, Rock K, Azmi A, Salib O, et al
    An atlas to aid delineation of para-aortic lymph node region in cervical cancer: Design and validation of contouring guidelines.
    Radiother Oncol. 2018 Mar 6. pii: S0167-8140(18)30084.
    PubMed     Abstract available


    February 2018
  38. GERBER R, Rink A, Croke J, Borg J, et al
    Comparison of dosimetric parameters derived from whole organ and wall contours for bladder and rectum in cervical cancer patients treated with intracavitary and interstitial brachytherapy.
    Radiother Oncol. 2018 Feb 6. pii: S0167-8140(18)30041.
    PubMed     Abstract available


    November 2017
  39. SMOLIC M, Sombroek C, Bloemers MCWM, van Triest B, et al
    Needle use and dosimetric evaluation in cervical cancer brachytherapy using the Utrecht applicator.
    Radiother Oncol. 2017 Nov 29. pii: S0167-8140(17)32723.
    PubMed     Abstract available


    September 2017
  40. NOVAKOVA E, Heijkoop ST, Quint S, Zolnay AG, et al
    What is the optimal number of library plans in ART for locally advanced cervical cancer?
    Radiother Oncol. 2017 Sep 19. pii: S0167-8140(17)32557.
    PubMed     Abstract available


    May 2017
  41. DEL CAMPO ER, Rivera S, Martinez-Paredes M, Hupe P, et al
    Assessment of the novel online delineation workshop dummy run approach using FALCON within a European multicentre trial in cervical cancer (RAIDs).
    Radiother Oncol. 2017 May 19. pii: S0167-8140(17)30372.
    PubMed     Abstract available


  42. LI N, Noticewala SS, Williamson CW, Shen H, et al
    Feasibility of atlas-based active bone marrow sparing intensity modulated radiation therapy for cervical cancer.
    Radiother Oncol. 2017;123:325-330.
    PubMed     Abstract available


    April 2017
  43. DE BOER P, Jurgenliemk-Schulz IM, Westerveld H, de Leeuw AAC, et al
    Patterns of care survey: Radiotherapy for women with locally advanced cervical cancer.
    Radiother Oncol. 2017 Apr 20. pii: S0167-8140(17)30145.
    PubMed     Abstract available


  44. ANDREYCHENKO A, Kroon PS, Maspero M, Jurgenliemk-Schulz I, et al
    The feasibility of semi-automatically generated red bone marrow segmentations based on MR-only for patients with gynecologic cancer.
    Radiother Oncol. 2017;123:164-168.
    PubMed     Abstract available


    March 2017
  45. VAN HEERDEN LE, Houweling AC, Koedooder K, van Kesteren Z, et al
    Structure-based deformable image registration: Added value for dose accumulation of external beam radiotherapy and brachytherapy in cervical cancer.
    Radiother Oncol. 2017 Mar 31. pii: S0167-8140(17)30111.
    PubMed     Abstract available


  46. MENDEZ LC, Weiss Y, D'Souza D, Ravi A, et al
    Three-dimensional-guided perineal-based interstitial brachytherapy in cervical cancer: A systematic review of technique, local control and toxicities.
    Radiother Oncol. 2017 Mar 25. pii: S0167-8140(17)30101.
    PubMed     Abstract available


    February 2017
  47. YAMAZAKI H, Nakamura S, Suzuki G, Yoshida K, et al
    Comment on "Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer" Kari Tanderup et al.
    Radiother Oncol. 2017 Feb 22. pii: S0167-8140(17)30067.
    PubMed    


  48. RAMLOV A, Assenholt MS, Jensen MF, Gronborg C, et al
    Clinical implementation of coverage probability planning for nodal boosting in locally advanced cervical cancer.
    Radiother Oncol. 2017 Feb 9. pii: S0167-8140(17)30040.
    PubMed     Abstract available


    January 2017
  49. SHACK L, Lu S, Weeks LA, Craighead P, et al
    Determining the need and utilization of radiotherapy in cancers of the breast, cervix, lung, prostate and rectum: A population level study.
    Radiother Oncol. 2017;122:152-158.
    PubMed     Abstract available


    November 2016
  50. EMINOWICZ G, Rompokos V, Stacey C, Hall L, et al
    Understanding the impact of pelvic organ motion on dose delivered to target volumes during IMRT for cervical cancer.
    Radiother Oncol. 2016 Nov 16. pii: S0167-8140(16)34365.
    PubMed     Abstract available


    January 2016
  51. WYSS JC, Carmona R, Karunamuni RA, Pritz J, et al
    [(18)F]Fluoro-2-deoxy-2-d-glucose versus 3'-deoxy-3'-[(18)F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients.
    Radiother Oncol. 2016;118:72-8.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: